ADMA Biologics Inc. (ADMA)

Strong performance of Asceniv continues to boost ADMA. We recommend the stock to investors due to its solid long-term fundamentals.

Here is how Adma Biologics (ADMA) and Agilon Health (AGL) have performed compared to their sector so far this year.

Zacks.com users have recently been watching Adma Biologics (ADMA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

If you are looking for stocks that are well positioned to maintain their recent uptrend, Adma Biologics (ADMA) could be a great choice. It is one of the several stocks that passed through our "Recent ...

Five mid-cap high-flying stocks to buy are: ADMA, FCFS, LRN, LTH, NFG.

Adma Biologics (ADMA) closed the most recent trading day at $24.11, moving -1.63% from the previous trading session.

Adma Biologics (ADMA) concluded the recent trading session at $21.31, signifying a +0.38% move from its prior day's close.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe...

Here is how Adma Biologics (ADMA) and Agilon Health (AGL) have performed compared to their sector so far this year.

Adma Biologics (ADMA) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, ADMA crossed above the 20-day moving average, suggestin...